Multi-Site Trial of Tirzepatide for Smoking Cessation (NCT07602699)
A Multi-Site Trial of Tirzepatide for Smoking Cessation
🩺 Plain-English Summary (8th-Grade Level)
This multi-site clinical trial will generate data on the efficacy of tirzepatide for smoking cessation and associated outcomes (e.g., post-cessation weight gain) in treatment-seeking people who smoke (PWS) with overweight or obesity. A sample of 300 treatment-seeking people who smoke with body mass index of 25 kg/m2 or greater will be recruited from four geographic sites (University of Southern California, Yale University, University of Chicago, and University of Colorado Anschutz Medical Campus) to participate in a parallel-arm, dose-escalating, placebo-controlled trial. Participants will attend weekly clinic visits to receive subcutaneous tirzepatide or placebo over 16 weeks (Visit Weeks 1-16), followed by follow-up visits at Week 17 and Week 27. Medication will be prescribed according to the standard dose titration schedule for the first 16 weeks of treatment (initial dose: 2.5mg/week; final dose: 10mg/week). All participants will also receive nicotine patches.
Who can join: Review the eligibility criteria below.
Location: Keck School of Medicine, University of Southern California — Los Angeles, California
Age range: 21 Years to 65 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- Keck School of Medicine, University of Southern California — Los Angeles, California
- University of Colorado Anschutz Medical Campus — Aurora, Colorado
- Yale University School of Medicine — New Haven, Connecticut
- University of Chicago Pritzker School of Medicine — Chicago, Illinois
📞 Contact the Study Coordinator
Phone: (213) 962-0698
Email: thomas.gilmore@usc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Smoking Cessation
- Acceptability of Mobile Applications (Apps) to Enhance Smoking Cessation in a Clinical Tobacco Treatment Program - A Pilot Study — Houston, Texas
- Telephone All Nations Breath of Life — Bethlehem, Pennsylvania
- A Randomized Clinical Trial Assessing Smoking Cessation Interventions In Dental Clinic Smokers — New York, New York
- Pharmacist Intervention to Improve Smoking Cessation — Iowa City, Iowa
- Urban and Reservation Implementation of All Nations Breath of Life — Bethlehem, Pennsylvania
- Smoking Cessation Program in the Construction Sector — Miami, Florida
Explore by condition: All Smoking Cessation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.